TB
Tony Butler Rodman & Renshaw Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Atara Biotherapeutics
ATRA
$90.7M
| $12.91 | $25 |
94%
upside
| Buy |
20 Dec ‘24
8 months ago |
|
|
HURA
2
TuHURA Biosciences, Inc. Common Stock
HURA
$128M
| $2.55 | $11 |
331%
upside
| Buy |
19 Dec ‘24
8 months ago |
|
3
Biomea Fusion
BMEA
$114M
| $1.92 | $18 |
838%
upside
| Buy |
26 Sep ‘24
11 months ago |
|
4
Mural Oncology
MURA
$35.9M
| $2.07 | $15 |
625%
upside
| Buy |
28 Jun ‘24
1 year ago |
|
5
Leap Therapeutics
LPTX
$11.7M
| $0.2830 | $8 |
2,727%
upside
| Buy |
28 Jun ‘24
1 year ago |
|
6
Century Therapeutics
IPSC
$43.6M
| $0.5047 | $16 |
3,070%
upside
| Buy |
10 Aug ‘23
2 years ago |
|
|
ADAP
7
Adaptimmune Therapeutics
ADAP
$10.9M
| $0.0410 | $10 |
24,290%
upside
| Buy |
10 Aug ‘23
2 years ago |
|
8
Fate Therapeutics
FATE
$116M
| $1.01 | $10 |
890%
upside
| Buy |
9 Aug ‘23
2 years ago |
|
9
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $75 |
37%
upside
| Buy |
8 Aug ‘23
2 years ago |
|
10
Merus
MRUS
$5.1B
| $67.47 | $35 |
48%
downside
| Buy |
8 Aug ‘23
2 years ago |
|
11
GT Biopharma
GTBP
$3.36M
| $0.9450 | $60 |
6,249%
upside
| Hold |
7 Aug ‘23
2 years ago |
|
12
Compugen
CGEN
$134M
| $1.43 | $13 |
809%
upside
| Buy |
7 Aug ‘23
2 years ago |
|
|
BCYC
13
Bicycle Therapeutics
BCYC
$496M
| $7.16 | $50 |
598%
upside
| Buy |
3 Aug ‘23
2 years ago |
|
14
Allogene Therapeutics
ALLO
$255M
| $1.15 | $15 |
1,204%
upside
| Buy |
3 Aug ‘23
2 years ago |
|
15
BioAtla
BCAB
$31.5M
| $0.5365 | $25 |
4,560%
upside
| Buy |
2 Aug ‘23
2 years ago |
|
|
16
Biomea Fusion
BMEA
$114M
| $1.92 | $43 |
2,140%
upside
| Buy |
1 Aug ‘23
2 years ago |
|
17
Pyxis Oncology
PYXS
$118M
| $1.91 | $15 |
685%
upside
| Buy |
31 Jul ‘23
2 years ago |
|
18
CEL-SCI Corp
CVM
$72.2M
| $10.49 | $10 |
5%
downside
| Buy |
12 Jul ‘23
2 years ago |
|
19
CalciMedica
CALC
$43M
| $3.08 | $17 |
452%
upside
| Buy |
7 Jul ‘23
2 years ago |
|
|
AGEN
20
Agenus
AGEN
$138M
| $4.33 | $166 |
3,734%
upside
| Buy |
3 Jul ‘23
2 years ago |
|
21
Replimune Group
REPL
$494M
| $6.33 | $60 |
848%
upside
| Buy |
7 Jun ‘23
2 years ago |
|
22
IN8bio
INAB
$9.83M
| $2.17 | $240 |
10,960%
upside
| Buy |
5 Jun ‘23
2 years ago |
|
23
VolitionRX
VNRX
$64.8M
| $0.6020 | $6 |
897%
upside
| Buy |
1 Jun ‘23
2 years ago |
|
24
HCW Biologics
HCWB
$9.12M
| $4.24 | $360 |
8,391%
upside
| Buy |
1 Jun ‘23
2 years ago |
|
|
25
Atara Biotherapeutics
ATRA
$90.7M
| $12.91 | $625 |
4,741%
upside
| Buy |
5 Jan ‘23
2 years ago |
|